March’s FDA approvals feature new biosimilars, first-in-class therapies, expanded indications, and diagnostic innovations across allergy, cardiology, gastroenterology, infectious diseases, and more.
New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.
FDA approves Vykat XR as first treatment for hyperphagia in patients with Prader-Willi syndrome; decision follows extended review and long-term efficacy data.
Reuters
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Researchers have identified the Alternative Healthy Eating Index as the most effective dietary pattern for promoting healthy aging, with plant-based foods and moderate healthy animal proteins supporting cognitive, physical, and mental health into later years.
"Partial weight regain after substantial weight loss was associated with a less favorable cardiovascular risk profile and an increased incidence of both microvascular and macrovascular diseases."